Semaglutide don nau'in ciwon sukari na 2
Cikakken Bayani
| Suna | Semaglutide |
| Lambar CAS | 910463-68-2 |
| Tsarin kwayoyin halitta | C187H2991N45o59 |
| Nauyi na kwayoyin | 4113.5754 |
| Lambar Einecs | 203-4055-2 |
Kwatanci
Sermaglutide; Semaglutide finganacheem; Semagullurtacce; Sermaglutide USP / EP; Semaglutode; Sermaglutide cas 910463 68 2; Ozempic,
Siffantarwa
Semaglutide sabon ƙarni na glp-1 (Glucagon-kamar peptide-1) Analogs, da Semaglutide Stiption Stive ne wanda ya dogara gwargwado bisa tsarin diabates 2. Novo Nordisk ya kammala karatun 6 na jihar Semaglutide, kuma gabatar da sabon aikace-aikacen Semaglutide a kan Semaglutide sati 5, 2016. An kuma gabatar da aikace-aikacen Izini a watan Disamba (EMA).
Idan aka kwatanta da Liraaglutide, Semaglutide yana da sarkar alippatic da qarshe tare da gajeriyar sarkar peg, kuma an inganta Semaglutoli sosai tare da gajeriyar sarkar sarkoki, da kuma hydrophiliciticty yana inganta. Bayan gyara bututu, ba zai iya kawai da kuka daɗaɗɗa ba a kan shafin yanar gizo na DPP-4, amma kuma yana rage tasirin rayuwar mutum, kuma ku cimma sakamako mai gudana.
Roƙo
Semaglutide shine tsarin sashi mai tsayi da yawa dangane da tsarin tushen Laftaaglutide, wanda ya fi tasiri wajen kula da nau'in sukari na 2.
M
Semaglutide (Rybelsus, Ozempic, NN9535, OGP0SSC, NNC013-0217-02ptaway 1 (T2DM).
Tsarin inganci
Gabaɗaya, tsarin inganci da tabbataccen tsari shine a wurin da yake rufe duk matakan samar da samfurin da aka gama. An yi isasshen masana'antu da ayyukan sarrafawa don bin ka'idodin da aka yarda da shi / bayanai. Canza iko da tsarin karkacewa shine a wurin, kuma an gudanar da kimantawa na tasirin da akeyi. Hanyoyin da suka dace suna cikin wurin don tabbatar da ingancin samfurin kafin saki cikin kasuwa.
